GLP-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease: A Review
Cardiology in review · 2026 Nov 3 · Rahni S, Lebovics E, Frishman WH et
MH
By Maren Holt · Senior Reporter, GLP-1
Nov 2 19:00 ETSource: Cardiology in review
From the source
Read at pubmed.ncbi.nlm.nih.govGLP-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease: A Review
Cardiology in review · 2026 Nov 3 · Rahni S, Lebovics E, Frishman WH et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42975978/
